MYUNGMOON Pharm co.,Ltd (017180.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 62.81B |
| Enterprise Value | 155.61B |
| P/E Ratio | 15.24 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 0.21 |
| Price/Book Ratio | 0.42 |
| Enterprise/Revenue | 0.68 |
| Enterprise/EBITDA | 12.42 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.04 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 195.25B |
| Revenue/Share | 5,904.3 |
| Gross Profit | 107.19B |
| EBITDA | 10.13B |
| Net Income | 1.9B |
| Diluted EPS | 56.7 |
Balance Sheet
| Total Cash | 4.56B |
| Total Cash/Share | 136.42 |
| Total Debt | 97.74B |
| Total Debt/Equity | 1 |
| Current Ratio | 0.95 |
| Book Value Per Share | 3,093.29 |
Price History
| 52-Week Change | -26.6 |
| 52-Week High | 2,055 |
| 52-Week Low | 1,199 |
| Moving Average 50 Days | 1,591.98 |
| Moving Average 200 Days | 1,726.4 |
Statistics
| Average Volume | 99,496 |
| Shares Outstanding | 33.43M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 513:500 |
| Last Split Date | May 14, 2020 |
AD
